The Presence of m1 to m5 Receptors in Human Sclera: Evidence of the Sclera as a Potential Site of Action for Muscarinic Receptor Antagonists

REFERENCES

• McBrien N A, Gentle A. Role of the sclera in the development and pathological complications of myopia. Prog Retin Eye Res 2003; 22: 307–338, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Christensen A M, Wallman J. Evidence that increased scleral growth underlies visual deprivation myopia in chicks. Invest Ophthalmol Vis Sci 1991; 32: 2143–2150, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Gottlieb M D, Joshi H B, Nickla D L. Scleral changes in chicks with form-deprivation myopia. Curr Eye Res 1990; 9: 1157–1165, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Phillips J R, Khalaj M, McBrien N A. Induced myopia associated with increased scleral creep in chick and tree shrew eyes. Invest Ophthalmol Vis Sci 2000; 41: 2028–2034, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Gentle A, McBrien N A. Modulation of scleral DNA synthesis in development of and recovery from induced axial myopia in the tree shrew. Exp Eye Res 1999; 68: 155–163, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Luft W A, Ming Y, Stell W K. Variable effects of previously untested muscarinic receptor antagonists on experimental myopia. Invest Ophthalmol Vis Sci 2003; 44: 1330–1338, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Yen M Y, Liu J H, Kao S C, Shiao C H. Comparison of the effect of atropine and cyclopentolate on myopia. Ann Ophthalmol 1989; 21: 180–182, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Vogel R. Pharmaceutical agents and the prevention or reduction of progressive myopia. Acta Ophthalmol Suppl 1988; 185: 134–138, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Duncan G, Collison D J. Role of the non-neuronal cholinergic system in the eye. Life Sci 2003; 72: 2013–2019, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Lind G J, Chew S J, Marzani D, Wallman J. Muscarinic acetylcholine receptor antagonists inhibit chick scleral chondrocytes. Invest Ophthalmol Vis Sci 1998; 39: 2217–2231, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Rada J A, Johnson J M, Achen V R, Rada K G. Inhibition of scleral proteoglycan synthesis blocks deprivation-induced axial elongation in chicks. Exp Eye Res 2002; 74: 205–215, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Buchli R, Ndoye A, Rodriguez J G, et al. Identification and characterization of muscarinic acetylcholine receptor subtypes expressed in human skin melanocytes. Mol Cellular Biochem 2001; 228: 57–72, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Collison D J, Coleman R A, James R S, et al. Characterization of muscarinic receptors in human lens cells by pharmacologic and molecular techniques. Invest Ophthalmol Vis Sci 2000; 41: 2633–2641, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Gil D W, Krauss H A, Bogardus A M, Wolde Mussie E. Muscarinic receptor subtypes in human iris–ciliary body measured by immunoprecipitation. Invest Ophthalmol Vis Sci 1997; 38: 1434–1442, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Truong H T, Cottriall C L, McBrien N A. Expression of muscarinic receptors in tree shrew ocular tissues. Invest Ophthalmol Vis Sci 2000; 41: S132, [CSA]
   PubMed Web of Science ®Google Scholar
• Tigges M, Tigges J, Rees H, et al. Distribution of muscarinic cholinergic receptor proteins m1 to m4 in area 17 of normal and monocularly deprived rhesus monkeys. J Comp Neurol 1997; 388: 130–145, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Schliebs R, Bigl V, Biesold D. Development of muscarinic cholinergic receptor binding in the visual system of monocularly deprived and dark reared rats. Neurochem Res 1982; 7: 1181–1198, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Vessey K A, Cottriall C L, McBrien N A. Muscarinic receptor protein expression in the ocular tissues of the chick during normal and myopic eye development. Brain Res Dev Brain Res 2002; 135: 79–86, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Tigges M, Iuvone P M, Fernandes A, et al. Effects of muscarinic cholinergic receptor antagonists on postnatal eye growth of rhesus monkeys. Optom Vis Sci 1999; 76: 397–407, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Fischer A J, Miethke P, Morgan I G, Stell W K. Cholinergic amacrine cells are not required for the progression and atropine-mediated suppression of form-deprivation myopia. Brain Res 1998; 794: 48–60, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Yin G C, Gentle A, McBrien N A. Muscarinic antagonist control of myopia: A molecular search for the M1 receptor in chick. Mol Vis 2004; 10: 787–793, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Schwahn H N, Kaymak H, Schaeffel F. Effects of atropine on refractive development, dopamine release, and slow retinal potentials in the chick. Vis Neurosci 2000; 17: 165–176, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Gordonson L C. Interventions to retard myopia progression. Ophthalmology 2003; 110: 1287, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Pollard Z F. A report of two more supporters of the medical management of myopia with topical atropine eyedrops and photochromic bifocals. Binocul Vis Strabismus Q 2002; 17: 177, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Kennedy R H, Dyer J A, Kennedy M A, et al. Reducing the progression of myopia with atropine: A long term cohort study of Olmsted County students. Binocul Vis Strabismus Q 2000; 15: 281–304, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Hu D N, McCormick S A, Ritch R, Pelton-Henrion K. Studies of human uveal melanocytes in vitro: Isolation, purification and cultivation of human uveal melanocytes. Invest Ophthalmol Vis Sci 1993; 33: 2210–2219, [CSA]
   Google Scholar
• Hu D N. Effect of TGF-β and cAMP-elevating agents on the growth of human scleral fibroblasts in vitro. Myopia Updates, L K Lin, Y F Shih, P T Hung, et al. Springer, Tokyo 2000; 131–132
   Google Scholar
• Santa Cruz Biotechnology, Inc, Santa Cruz city, CAUSA 2001, mAChR M1(H-120):sc-9106
   Google Scholar
• Santa Cruz Biotechnology, Inc, Santa Cruz city, CAUSA 2001, mAChR M2(H-170):sc-9107
   Google Scholar
• Santa Cruz Biotechnology, Inc, Santa Cruz city, CAUSA 2001, mAChR M3(H-210):sc-9108
   Google Scholar
• Santa Cruz Biotechnology, Inc, Santa Cruz city, CAUSA 2001, mAChR M4(H-175):sc-9109
   Google Scholar
• Santa Cruz Biotechnology, Inc, Santa Cruz city, CAUSA 2001, mAChR M5(H-197):sc-9110
   Google Scholar
• Newkirk R F, Mack J. Improved indirect fluorescence immunocytochemical method using counterstains. Biotechniques 1992; 13: 536–538, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Li Y Q, Chen P, Haimovitz-Friedman A, et al. Endothelial apoptosis initiates acute blood-brain barrier disruption after ionizing radiation. Cancer Res 2003; 15: 5950–5956, [CSA]
   Google Scholar
• Rada J A, Perry C A, Slover M L, Achen V R. Gelatinase A and TIMP-2 expression in the fibrous sclera of myopic and recovering chick eyes. Invest Ophthalmol Vis Sci 1999; 40: 3091–3099, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Khanna S, Porter J D. Evidence for rectus extraocular muscle pulleys in rodents. Invest Ophthalmol Vis Sci 2001; 42: 1986–1992, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Tuori A, Virtanen I, Aine E, Uusitalo H. The expression of tenascin and fibronectin in keratoconus, scarred and normal human cornea. Graefes Arch Clin Exp Ophthalmol 1997; 235: 222–229, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Zeng F, Wess J. Molecular aspects of muscarinic receptor dimerization. Neuropsychopharmacology 2000; 23: S19–S31, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Buchli R, Ndoye A, Rodriguez J G, et al. Human skin fibroblasts express m2, m4, and m5 subtypes of muscarinic acetylcholine receptors. J Cell Biochem 1999; 74: 264–277, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Grando S A, Zelickson B D, Kist D A, et al. Keratinocyte muscarinic acetylcholine receptors: Immunolocalization and partial characterization. J Invest Dermatol 1995; 104: 95–100, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ndoye A, Buchli R, Greenberg B, et al. Identification and mapping of keratinocyte muscarinic acetylcholine receptor subtypes in human epidermis. J Invest Dermatol 1998; 111: 101–108, [CSA], [CROSSREF]
   Web of Science ®Google Scholar
• Liles W C, Nathanson N M. Regulation of neuronal muscarinic acetylcholine receptor number by protein glycosylation. J Neurochem 1986; 46: 89–95, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Alge C S, Suppmann S, Priglinger S G, et al. Comparative Proteome analysis of native differentiated and cultured dedifferentiated human RPE cells. Invest Ophthalmol Vis Sci 2003; 44: 3629–3641, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Matsumoto S, Yorio T, DeSantis L, Pang I H. Muscarinic effects on cellular functions in cultured human ciliary muscle cells. Invest Ophthalmol Vis Sci 1994; 35: 3732–3738, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Ishizaka N, Noda M, Yokoyama S, et al. Muscarinic acetylcholine receptor subtypes in the human iris. Brain Res 1998; 787: 344–347, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Zhang X, Erickson K. Regulation of m3-muscarinic-receptor and messenger: RNA expression in cultured ciliary muscle-cells. Invest Ophthalmol Vis Sci 1995; 36: S593, [CSA]
   Web of Science ®Google Scholar
• Wiederholt M, Schafer R, Wagner U, Lepple–Wienhues A. Contractile response of the isolated trabecular meshwork and ciliary muscle to cholinergic and adrenergic agents. Ger J Ophthalmol 1996; 5: 146–153, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Wallman J. Nature and nurture of myopia. Nature 1994; 371: 201–202, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• McBrien N A, Moghaddam H O, Reeder A P. Atropine reduces experimental myopia and eye enlargement via a nonaccommodative mechanism. Invest Ophthalmol Vis Sci 1993; 34: 205–215, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar